medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Number 3

<< Back Next >>

Ann Hepatol 2017; 16 (3)

Spontaneous Resolution of Multiple Hepatic Masses: Hepatic Inflammatory Pseuduotumor

Qi X, Han L, Arora A, Hou Y, Wang R, Chang S, Guo X

Language: English
References: 9
Page: 457-459
PDF size: 135.63 Kb.


Text Extraction

CASE PRESENTATION

A previously healthy 59-year-old female presented with intermittent fever for 4 days. The highest temperature was 40°C. Buluofen was given at home, but fever relapsed. She denied any history of liver diseases. She did not smoke or have any history of alcohol or drug abuse. On physical examinations, there were no positive signs. At our admission, abnormal laboratory tests (2016-12-19) were primarily shown as follows: white blood cell was 12.3 x 109/L (reference range: 3.5-9.5 x 109/L), percentage of neutrophil was 81.9% (reference range: 40-75%), C reactive protein was 99.4 mg/L (reference range: 0-8 mg/L), procalcitonin was 0.378 ng/mL (reference range: 0-0.05 ng/mL), total bilirubin was 48.88 umol/L (reference range: 5.1-22.2 umol/L), direct bilirubin was 17.2 umol/L (reference range: 0-8.6 umol/L), aspartate aminotransferase was 111.68 U/L (reference range: 13-35 U/L), alanine aminotransferase was 181.88 (reference range: 7-40 U/L), alkaline phosphatase was 154.83 U/L (reference range: 35-135 U/L), gamma-glutamyl transferase was 164.91 U/L (reference range: 7-45 U/L), albumin was 38.2 g/L (reference range: 40-55 g/L), mycoplasma pneumoniae antibody IgM was weakly positive, and anti-influenza virus antibody IgM was weakly positive.


REFERENCES

  1. Pack GT, Baker HW. Total right hepatic lobectomy; report of a case. Ann Surg 1953; 138: 253-8. 2016-12-05 2017-01-10 2017-02-28 Contrast-enhanced CT venous phase Contrast-enhanced MR venous phase Contrast-enhanced MR venous phase Figure 1. Contrast enhanced CT and MRI images of the liver.

  2. Wu CH, Chiu NC, Yeh YC, Kuo Y, Yu SS, Weng CY, Liu CA, et al. Uncommon liver tumors: Case report and literature review. Medicine (Baltimore) 2016; 95: e4952.

  3. Tang L, Lai EC, Cong WM, Li AJ, Fu SY, Pan ZY, Zhou WP, et al. Inflammatory myofibroblastic tumor of the liver: a cohort study. World J Surg 2010; 34: 309-13.

  4. Balabaud C, Bioulac-Sage P, Goodman ZD, Makhlouf HR. Inflammatory pseudotumor of the liver: a rare but distinct tumor- like lesion. Gastroenterol Hepatol (NY) 2012; 8: p. 633-4.

  5. Narla LD, Newman B, Spottswood SS, Narla S, Kolli R. Inflammatory pseudotumor. Radiographics 2003; 23(3): 719-29.

  6. Sanders BM, West KW, Gingalewski C, Engum S, Davis M, Grosfeld JL. Inflammatory pseudotumor of the alimentary tract: clinical and surgical experience. J Pediatr Surg 2001; 36: 169-73.

  7. Aguirre-Garcia J. Inflammatory pseudotumor of the liver. Ann Hepatol 2004; 3:34.

  8. Zavaglia C, Barberis M, Gelosa F, Cimino G, Minola E, Mondazzi L, Bottelli R, et al. Inflammatory pseudotumour of the liver with malignant transformation. Report of two cases. Ital J Gastroenterol 1996; 28: 152-9.

  9. Pecorella I, Ciardi A, Memeo L, Trombetta G, de Quarto A, de Simone P, di Tondo U. Inflammatory pseudotumour of the liver-evidence for malignant transformation. Pathol Res Pract 1999; 195: 115-20.




2020     |     www.medigraphic.com